Takeda To Supply Anemia Drug To Major U.S. Dialysis Center Operator
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceutical has agreed to supply its Omontys (peginesatide) drug used in kidney dialysis to Germany's Fresenius Medical Care, which operates more than 100 U.S. dialysis centers.